BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2722404)

  • 1. Childhood's enuresis in the history of women with hyperprolactinemic amenorrhea.
    Fava M; Guaraldi GP; Borofsky GL; Mastrogiacomo I
    Int J Psychiatry Med; 1989; 19(1):41-6. PubMed ID: 2722404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression hostility and anxiety in hyperprolactinemic amenorrhea.
    Fava GA; Fava M; Kellner R; Serafini E; Mastrogiacomo I
    Psychother Psychosom; 1981; 36(2):122-8. PubMed ID: 7200625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prolactin and estrogen deficiency in amenorrheic bone loss.
    Klibanski A; Biller BM; Rosenthal DI; Schoenfeld DA; Saxe V
    J Clin Endocrinol Metab; 1988 Jul; 67(1):124-30. PubMed ID: 3379129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea.
    MacGregor C; Maldonado D; Canales ES; Soria J; Zárate A
    Acta Obstet Gynecol Scand; 1977; 56(4):333-6. PubMed ID: 414510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosomatic aspects of hyperprolactinemia.
    Fava M; Fava GA; Kellner R; Buckman MT; Lisansky J; Serafini E; DeBesi L; Mastrogiacomo I
    Psychother Psychosom; 1983; 40(1-4):257-62. PubMed ID: 6657880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial aspects of hyperprolactinemia.
    Assies J; Vingerhoets AJ; Poppelaars K
    Psychoneuroendocrinology; 1992 Nov; 17(6):673-9. PubMed ID: 1287685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression and hostility in hyperprolactinemia.
    Fava M; Fava GA; Kellner R; Serafini E; Mastrogiacomo I
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):479-82. PubMed ID: 6891814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of Macroprolactin in Hyperprolactinemia.
    Sherazi NA; Baig MZ; Khan AH
    J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlations between hyperprolactinemia and galactorrhea].
    Romero Gutierrez G; Aguirre Beltran AF; Figueroa Solana MI; Malacara Hernandez JM
    Ginecol Obstet Mex; 1989 Nov; 57():294-7. PubMed ID: 2486966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinemia and psychological distress in women undergoing chronic hemodialysis.
    Fava M; Serafini E; De Besi L; Adami A; Mastrogiacomo I
    Psychother Psychosom; 1988; 49(1):6-9. PubMed ID: 3237963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of growth hormone to metoclopramide in normal women and amenorrheic women with or without hyperprolactinemia.
    Seki K; Kato K
    Endocrinol Jpn; 1986 Oct; 33(5):721-5. PubMed ID: 3830074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea.
    Chang RJ; Keye WR; Young JR; Wilson CB; Jaffe RB
    Am J Obstet Gynecol; 1977 Jun; 128(4):356-63. PubMed ID: 559413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of hyperprolactinemia in 70 women with amenorrhea.
    Potashnik G; Bar-Ziv J; Glick S; Shoham A; Ben-Aderet N
    Isr J Med Sci; 1978 Jul; 14(7):753-61. PubMed ID: 681167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating nitric oxide levels in galactorrheic, hyperprolactinemic, amenorrheic women.
    Shaarawy M; Nafei S; Abul-Nasr A; el-Sharkawy S; Younis A
    Fertil Steril; 1997 Sep; 68(3):454-9. PubMed ID: 9314914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia, amenorrhea, and galactorrhea. A retrospective assessment of twenty-five cases.
    Koppelman MC; Jaffe MJ; Rieth KG; Caruso RC; Loriaux DL
    Ann Intern Med; 1984 Jan; 100(1):115-21. PubMed ID: 6537879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturnal melatonin and luteinizing hormone rhythms in women with hyperprolactinemic amenorrhea.
    Luboshitzky R; Lavi S; Thuma I; Lavie P
    J Pineal Res; 1996 Mar; 20(2):72-8. PubMed ID: 8815190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia.
    Schlechte J; Walkner L; Kathol M
    J Clin Endocrinol Metab; 1992 Sep; 75(3):698-703. PubMed ID: 1517357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.
    Nicoletti I; Filipponi P; Sfrappini M; Fedeli L; Petrelli S; Gregorini G; Santeusanio F; Brunetti P
    Horm Res; 1984; 19(3):158-70. PubMed ID: 6425187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.
    Gheri RG; Boddi W; Ammannati F; Olivotto J; Nozzoli C; Franchi A; Bordi L; Luisi ML; Mennonna P
    J Endocrinol Invest; 1997 Apr; 20(4):240-4. PubMed ID: 9211134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum prolactin levels in postpill amenorrheic patients.
    Karaman AS; Uran B; Erler A
    Int J Gynaecol Obstet; 1993 Nov; 43(2):177-80. PubMed ID: 7905434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.